EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,250,411 | +75.0% | 142,702 | +115.8% | 0.00% | – |
| Q2 2023 | $1,285,704 | +49791.5% | 66,137 | -27.2% | 0.00% | -100.0% |
| Q1 2023 | $2,577 | +13.2% | 90,822 | +16.5% | 0.00% | 0.0% |
| Q4 2022 | $2,277 | -99.9% | 77,932 | +20.0% | 0.00% | 0.0% |
| Q3 2022 | $1,715,000 | -43.2% | 64,919 | -4.4% | 0.00% | 0.0% |
| Q2 2022 | $3,017,000 | +46.7% | 67,895 | +61.5% | 0.00% | 0.0% |
| Q1 2022 | $2,057,000 | +7.8% | 42,036 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $1,909,000 | -28.2% | 41,622 | -12.6% | 0.00% | 0.0% |
| Q3 2021 | $2,658,000 | +27.8% | 47,648 | -1.9% | 0.00% | 0.0% |
| Q2 2021 | $2,079,000 | -5.6% | 48,584 | -7.9% | 0.00% | 0.0% |
| Q1 2021 | $2,202,000 | -8.1% | 52,743 | +2.5% | 0.00% | 0.0% |
| Q4 2020 | $2,397,000 | +13.6% | 51,476 | +3.6% | 0.00% | 0.0% |
| Q3 2020 | $2,110,000 | -13.1% | 49,681 | -1.8% | 0.00% | 0.0% |
| Q2 2020 | $2,428,000 | +19.1% | 50,592 | +14.2% | 0.00% | 0.0% |
| Q1 2020 | $2,039,000 | -21.4% | 44,316 | +2.6% | 0.00% | 0.0% |
| Q4 2019 | $2,595,000 | +4.9% | 43,205 | -1.2% | 0.00% | 0.0% |
| Q3 2019 | $2,474,000 | +0.8% | 43,738 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $2,454,000 | – | 44,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |